Dapagliflozin Promising as Add-On Therapy in Young People With Type 2 Diabetes
Dapagliflozin can help children, adolescents and young adults with type 2 diabetes improve their A1c levels when added to other antidiabetes therapies, according to a randomized controlled trial.
Reuters Health Information
source https://www.medscape.com/viewarticle/972292?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/972292?src=rss
Comments
Post a Comment